Based on its unique formulation and reported mechanisms of action, OstokinPlus may be considered as an adjunctive therapy for the following conditions:
Avascular Necrosis (Osteonecrosis)
Aims to improve microcirculation in affected bone tissue
Supports osteoblast activity to promote bone regeneration
May help reduce osteoclast-mediated bone resorption
Osteoporosis
Designed to enhance bone mineral density through improved microcirculation
Supports osteoblast function to increase bone formation
May help regulate calcium metabolism and deposition
Bone Fractures
Aims to accelerate fracture healing by improving local blood flow
Supports the formation and activity of osteoblasts at the fracture site
May enhance the body's natural inflammatory response during early stages of healing
Herniated Discs
Designed to improve microcirculation in the intervertebral disc region
May support the repair of damaged annulus fibrosus and nucleus pulposus tissues
Aims to reduce local inflammation and promote tissue regeneration
Fibromyalgia
Targets to improve overall microcirculation, potentially alleviating widespread pain
Aims to modulate immune system function, which may be dysregulated in fibromyalgia
Supports cellular-level repair processes in muscles and connective tissues
Mechanism of Action
Ostokin Plus is formulated to regulate microcirculation, support liver and kidney functions, balance the immune system, and promote cellular-level repair. Its active ingredients, including Astragalus extract, safflower extract, and Type II collagen, work synergistically to potentially improve blood flow, repair capillaries, and support the body's natural healing processes.
Safety and Contraindications
Not recommended for patients on active chemothreapy treatments.
